Being given a whole new body might sound like something from a sci-fi movie - but a New Zealander says a new genetic treatment has felt just like that.
Hereditary angioedema is a rare immune deficiency that causes random, disabling and potentially lethal swelling.
It's estimated one in 50,000 people are living with the disorder.
But in Auckland, a world-first clinical trial has so far eradicated symptoms for the ten participants.
Niva Chittock reports.
